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Abstract This study evaluates possible circadian rhythms during prolonged pro-
pofol infusion in patients in the intensive care unit. Eleven patients were sedated
with a constant propofol infusion. The blood samples for the propofol assay were
collected every hour during the second day, the third day, and after the termination
of the propofol infusion. Values of electroencephalographic bispectral index (BIS),
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DOI 10.1007/s10928-010-9161-5arterial blood pressure, heart rate, blood oxygen saturation and body temperature
were recorded every hour at the blood collection time points. A two-compartment
model was used to describe propofol pharmacokinetics. Typical values of the
central and peripheral volume of distribution and inter-compartmental clearance
were VC = 27.7 l, VT = 801 l, and CLD = 2.73 l/min. The systolic blood pressure
(SBP) was found to inﬂuence the propofol metabolic clearance according to Cl
(l/min) = 2.65 (1 - 0.00714 (SBP - 135)). There was no signiﬁcant circadian
rhythm detected with respect to propofol pharmacokinetics. The BIS score was
assessed as a direct effect model with EC50 equal 1.98 mg/l. There was no signif-
icant circadian rhythm detected within the BIS scores. We concluded that the light–
dark cycle did not inﬂuence propofol pharmacokinetics and pharmacodynamics in
intensive care units patients. The lack of night–day differences was also noted for
systolic blood pressure, diastolic blood pressure and blood oxygenation. Circadian
rhythms were detected for heart rate and body temperature, however they were
severely disturbed from the pattern of healthy patients.
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Introduction
Both undersedation and oversedation have an obvious effect on morbidity and
mortality in critically ill patients [1]. The electroencephalographic (EEG) bispectral
index (BIS) has been shown to be a quantiﬁable measure of the hypnotic effect of
anesthetic drugs on the central nervous system [2–4]. A correlation between BIS
values and the administrated dose of intravenous and inhalational anesthetics has
been demonstrated: the progressive deepening of anesthesia induces a correspond-
ing progressive reduction in BIS values [5]. Doi et al. showed a good correlation
between BIS, propofol blood concentration and clinical sedation criteria in patients
undergoing minor surgery [6]. Similar results were obtained in the study of Lee in
respect to propofol effect site concentration and BIS values [7]. Park et al. [8]
observed moderate correlation (Spearman’s coefﬁcient r =- 0.559) between BIS
values and predicted plasma concentration of propofol during recovery from
propofol anesthesia in children.
In the literature different data exist with respect to the utility of BIS for
monitoring prolonged sedation especially in the critically ill or mechanically
ventilated patients. Data on BIS monitoring in the intensive care unit (ICU) are
controversial. Leslie et al. [9] noted that BIS decreases linearly as propofol blood
concentrations increase in healthy male volunteers. Simmons et al. [10] studied 62
mechanically ventilated patients and demonstrated good correlation between BIS
and the SAS (Sedation–Agitation Scale), however the correlation varied in medical,
surgical and trauma patients. Riker et al. [11] found good correlation between BIS
and the SAS although the authors noted that electromyographic interference could
affect the accuracy of BIS. Frenzel et al. [12] examined the correlation between BIS
values and different clinical depth of sedation scales (OAAS, modiﬁed Ramsay
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19 patients who required mechanical ventilation for more than 24 h. The authors
noted moderate correlation between BIS and each sedation score in 11 patients and
no correlation in 8 patients. They found no parameters distinguishing between these
two groups. Riess et al. [13] noted that although BIS correlates with Ramsay
sedation score in critically ill patients, electromyographic activity and the patients’
temperature instability increases BIS values.
In critically ill patients, the alterations of pharmacokinetics and a high
interpatient variability of the pharmacodynamic effect can be seen. A common
complication of sedation is tolerance, which can modify the concentration-effect-
relationship [14]. When a drug in prolonged infusion is administered, circadian
rhythms also have to be taken into account as factors inﬂuencing both
pharmacokinetics and pharmacodynamics. Animal studies have shown that the
maximum hypnotic effect of general anesthetics is generally obtained during the
rest phase [15]. Challet et al. [16] recently demonstrated that the duration of
propofol anesthesia in rats exhibits a three-fold amplitude variation, depending on
the hour of administration. The longest duration occurred during the natural sleep
period (30 vs. 10 min during the activity phase). The authors did not measure
blood concentrations in this study. It is possible that their observations resulted
partly from circadian ﬂuctuations in pharmacokinetic properties. However, such
ﬂuctuations in propofol pharmacodynamics should also be taken into consider-
ation. It has been observed that sedative effect of propofol is mediated by
GABAA receptors in an endogenous sleep pathway [17]. No literature data
reﬂecting propofol chronopharmacokinetics and chronopharmacodynamics in
humans exist.
The aim of our study was to propose pharmacokinetic (PK) and pharmacody-
namic (PD) models of propofol and to examine the circadian rhythms in propofol
concentrations, sedative effects as well as the time-dependent changes in the
monitored physiological parameters during prolonged propofol infusion in ICU
patients.
Materials and methods
Patients
The study was performed with approval of the local Ethics Committee in 11 ICU
patients of both genders. The exclusion criteria were: administration of neuromus-
cular blockers, head trauma and known neurological disorders that might alter EEG
interpretation: metabolic or hypoxic encephalopathy, meningoencephalitis, stroke,
tumors and perinatal neurologic disorders. Bispectral Index was measured using an
EEG monitor (BIS, Monitor Intelli Vue MP60, Philips). Patients had conventional
monitoring with at least electrocardiographic monitoring, arterial blood pressure
monitoring, body temperature monitoring, and pulseoximetry. Patients were studied
in the absence of stimulation when they were clinically stable. Vasopressors had not
been given during the study period.
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Germany) for more than 24 h, and the infusion rate was constant during the study
period, except patient 6, who required changes in the infusion rate. Patient 3 was
excluded from analysis since no blood samples were collected. The initial
propofol dose was 1.5 mg per kg followed by maintenance doses of 0.7–0.9
mg/kg/h. Blood samples for the propofol assay were collected from the patients’
artery every hour during the second and third day of infusion and then 3, 5, 10,
15, 30, 60, 120, 180, 240 min after termination of the propofol infusion. The
values of BIS, systolic (SBP) and distolic (DBP) blood pressure, heart rate (HR),
blood oxygen saturation (OXYG) and body temperature (TEMP) were recorded
every hour at the blood collection time points. The blood samples were transferred
into heparinised tubes and they were centrifuged immediately after collection. The
plasma was stored at 4C. The propofol concentration in plasma was measured
within eight weeks by high-performance liquid chromatography with a ﬂuores-
cence detector [18]. The limit of quantiﬁcation was estimated at 0.01 mg/l. The
within-day coefﬁcients of variation and the between-day coefﬁcients of variation
were less than 10%.
Population pharmacokinetic modeling
Population nonlinear mixed-effect modeling was done using NONMEM (Version
6.1.0, Icon Development Solutions, Ellicott City, MD, USA) and the Intel Fortran
Compiler 9.0. NONMEM runs were executed using Wings for NONMEM
(WFN611, http://wfn.sourceforge.net). The ﬁrst-order conditional estimation with
interaction (FOCE) method was used. The minimum value of the NONMEM
objective function (MOF), typical goodness-of-ﬁt diagnostic plots, and an evalua-
tion of the precision of pharmacokinetic parameter and variability estimates were
used to discriminate between various models during the model-building process.
PK/PD model of propofol
The propofol concentration in the plasma versus time (t) was described by a two-
compartment model (ADVAN3, TRANS4):
VC
dCP
dt
¼ Input   Cl   CP   ClD   CP þ ClD   CT
VT
dCT
dt
¼ ClD   Cp   ClD   CT
ð1Þ
where CP and CT are the propofol concentrations in the central and peripheral
compartment, VC and VT denote the volumes of the central and peripheral
compartment, and Cl and ClD denotes the metabolic and inter-compartmental
clearance. The input reﬂects the infusion rate and all extra boluses that were given to
individual patients.
The time course of electroencephalographic (EEG) bispectral index (BIS) has
been described by a direct effect model:
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123BISðtÞ¼BIS0  
EmaxCP
EC50 þ CP
ð2Þ
where BIS0 denotes the baseline BIS score (fully awake). It was ﬁxed to 100. The
Emax is the maximal effect also ﬁxed to 100 and EC50 is the concentration for 50%
decrease in BIS score.
Inter-individual variability (IIV) for the PK/PD parameters was modeled
assuming log normal distribution:
P ¼ hP expðgPÞð 3Þ
where P is the individual parameter, hP is the typical value of this parameter in the
population, and gP is a random effect for that parameter with the mean 0 and
variance xP
2. The observed concentration of propofol and BIS score were deﬁned
by the following equations:
CP;obs ¼ CPð1 þ eprop;CÞð 4Þ
BISobs ¼ BISð1 þ eprop;BISÞð 5Þ
where CP and BIS are deﬁned by the Eq. 1 and 2 of the basic structural population
model and eprop,C and eprop,BIS represents the proportional residual random errors of
propofol concentrations and BIS scores. It was assumed that e is normally
distributed with the mean of 0 and variances denoted by rprop,C
2 and rprop,BIS
2 .
Covariate search and rhythm assessment
Covariate search was performed by plotting individual estimates of the PK/PD
parameters against time independent covariates (body weight, age, and initial
triglyceride concentration) to identify their inﬂuence. Similarly the time-dependent
covariates were identiﬁed by plotting the weighted residuals of the simple model
against the covariate. The time-dependent covariates were heart rate, systolic and
diastolic blood pressure, body temperature and blood oxygenation. The following
regression model was used:
P ¼ð hP1 þ hP2ðCOV   COVÞÞexpðgPÞð 6Þ
where the hP1 and hP2 are the regression coefﬁcients. The variables were centered
around their median values, COV, thus allowing hP1 to represent the parameter
estimate for the typical patient.
The major objective of this work was to seek the presence of the circadian
changes in propofol concentrations, BIS scores, and physiological parameters
routinely monitored during patient stays in an ICU. For that purpose the
metabolic clearance, EC50, heart rate, systolic and diastolic blood pressure and
body temperature were sought to be time-dependent according to the cosine
function:
P ¼ hP 1 þ hA;P cos
2p
24
ðt   hS;P þ TÞ
 
expðgPÞð 7Þ
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hP is a mesor (the average value around which the variable oscillates), hA,P is
amplitude, hS,P is the acrophase (the clock time at which the peak of a rhythm
occurs), and T is the clock time at the start of infusion. The equation assumes a 24 h
ﬁxed period and coverts time to radians.
The difference in the minimum of the NONMEM objective function (MOF)
obtained for the two hierarchical models (likelihood ratio) is approximately v
2
distributed. During the covariate and rhythm search the effect of each covariate was
examined by adding Eq. 6 or 7 to the base model. The likelihood ratio was
determined as the difference in the objective function (MOF) of a full model (with
covariate or with daily ﬂuctuations) and reduced model (without covariate or
without daily ﬂuctuations) after reﬁtting the data. The difference in MOF between
models of 10.8 for one degree of freedom and of 13.8 for two degrees of freedom
was considered to be statistically signiﬁcant at P\0.001 for the equation to be
included into the base model.
Results
The patient characteristics are presented in Table 1. Eight male and three female
patients were enrolled. The mean duration of the total propofol infusion was
98.4 ± 84.5 h. The mean duration of the propofol infusion during sample collection
(second and third day of infusion) was 38.17 ± 10.98 h and the mean steady-state
propofol concentration was 0.48 ± 0.21 mg/l.
The model building process started with a 3-compartment model according to
literature ﬁndings [19, 20]. However, a two-compartment model was sufﬁcient to
describe our data. The propofol PK during and after prolonged infusion is presented
in Fig. 1. This plot shows that the ﬁnal PK model describes the measured
concentrations well. The parameter estimates obtained by the ﬁtting of the PK data
are listed in Table 2. The typical value of the volume of the central compartment
Table 1 Demographic data and
physiological parameters of
subjects
Parameter, unit Mean ± SD (n = 11); range
Age, years 63 ± 11; 53–85
Body weight, kg 72.61 ± 22.79; 50–95
Height, cm 168.33 ± 8.66; 150–175
Body mass index 25.45 ± 7.02; 17.3–33.2
Male/female 8/3
Duration of the infusion
study period, h
38.17 ± 10.98; 25–49
Systolic blood pressure, mmHg 135.0 ± 19.4; 85–191
Diastolic blood pressure, mmHg 64.6 ± 10.0; 38–98
Heart rate, beats/min. 89.8 ± 15.7; 60–138
Body temperature, C 37.0 ± 0.5; 35.7–38.2
Blood oxygen saturation, % 97.4 ± 2.1; 90–100
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metabolic clearance for typical subject equaled 2.65 l/min. It was found to depend
on the systolic blood pressure according to CL (l/min)) = 2.65 (1 - 0.00714 
(SBP - 135)).This was the onlycovariate found toinﬂuence the model performance
with a decrease of 20.3 in MOF. The inter-compartmental clearance equaled
2.73 l/min. The selection of the IIV parameters was done according to the bottom-up
approach starting from clearance, as it drives the steady-state concentration, and
Fig. 1 Plot of observed (open circle), population predicted (dashed line) and individual predicted (Solid
line) propofol concentrations versus time for the ﬁnal PK model. The shaded area represents the dark
period (8 p.m.–8 a.m). Time denotes time that has passed since the start of infusion
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The IIV of clearance equaled 48.6%. We failed to estimate IIV for any other
parameters. The relative standard errors (%CV) of all estimates did not exceed 66%.
The pharmacodynamic model was based on the sigmoid Emax model presented in
the literature [21, 22]. The BIS score data along with model predictions are presented
in Fig. 2. These plots show that the PD model described the data reasonably well.
There are some parts of the data that are mis-predicted. This might be a consequence
of some irregular awakening and sedation periods that were not included into the
model, i.e., the daily care of patients by nurses or a short nap. The parameter
estimates of the PD model are listedin Table 3. The EC50 equaled 1.98 mg/l with IIV
of 45.1%. The parameters were estimated with high precision. The relative standard
error was lower than 36%. No covariates were identiﬁed for propofol PD.
Neither for the PK or PD of propofol did we observe circadian rhythms. The
inclusion of the daily ﬂuctuations in clearance or EC50 did not improve the basic
model performance. The MOF decreased by 4.9 for CL and by 13.5 for EC50, which
was not statistically signiﬁcant (P\0.001).
Signiﬁcant circadian rhythms were found for the heart rate (P\0.001) and body
temperature (P\0.001). The mesor, amplitude and acrophase estimates are given
in Table 4. The time course of body temperature and heart rate along with model
predictions (Eq. 7) is presented in Figs. 3 and 4. The heart rate and body
temperature were adequately described by the proposed model, however some mis-
predictions can be observed for temperature. The average heart rate was 90.5 beats/
min with moderate IIV of 14.7%. The amplitude was small and equaled 4.8% of the
messor. The acrophase was 14 h reﬂecting an increased heart rate during the day
with maximum at 02:00 p.m. The average body temperature was 37C with low IIV
of 0.82%. The amplitude was very small, 0.32% of the mesor. The acrophase was
21.4 h (21:24 p.m.). The lack of statistically signiﬁcant circadian rhythms was
observed with respect to SBP, DBP and blood oxygen saturation.
Table 2 Summary of the ﬁnal population PK parameters, inter-subject and residual error variance
estimates of propofol
Parameter, unit Basic PK model PK model with covariate
Estimate (% CV) Estimate (% CV)
Fixed effect
hCl, (l/min) 2.55 (16) 2.65 (15) (1 - 0.00714 (66) (SBP - 135)
hVC (l) 27.2 (24) 27.7 (27)
hCLD (l/min) 2.70 (24) 2.73 (28)
hVT (l) 785 (35) 801 (33)
Inter-individual variability
xCl
2 (%) 52.2 (50) 48.6 (50)
Residual variability
rprop,Cp
2 (%) 42.5 (21) 41.8 (17)
Performance measures
MOF -1085.1 -1105.4 (DMOF =- 20.3)
SBP denotes systolic blood pressure
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We assessed circadian rhythms during propofol constant infusion in critically ill
patients. A three-compartment model has been widely used in studying propofol PK
[19, 20]. However, in this work the presence of the third compartment was not
justiﬁed, since it manifests itself at the ﬁrst minutes after the end of infusion or bolus
administration whereas our post-infusion data collection started at 3 min. The
applied two-compartment model was also used for propofol PK, especially for
Fig. 2 Plot of observed (open circle), population predicted (dashed line) and individual predicted (solid
line) BIS scores versus time for the ﬁnal PD model. The shaded area represents the dark period
(8 p.m.–8 a.m). Time denotes time that has passed since the start of infusion
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was in agreement with literature data obtained in ICU patients, viz. 2.11 l/min [25],
1.57 l/min [26], 1.50 l/min [27], 1 l/min [19], 2.2 l/min [21] and 2.05 l/min [22].
Similarly the volume of distribution at steady-state (VSS = VP ? VT = 828 l) was
in agreement with literature data, namely 1699 l [25], 499 l [28], 1160 l [22], 190 l
[21], 4577 l [27], however VSS varies considerably across studies. Our results are
also comparable to the results of a multicenter population study [19]. A three-
compartment model gave the following parameters for a 70-kg adult: metabolic
clearance 1.44 l/min, inter-compartmental clearances 2.25 and 0.92 l/min, volume
of the central compartment 9.3 l and peripheral compartments 44.2 and 266 l.
In this work we identiﬁed the systolic blood pressure as a covariate affecting
metabolic clearance. Propofol is highly extracted drug due to its hepatic
metabolism. This results in dependence of clearance on liver blood ﬂow. It has
been shown that the rate of propofol clearance increased with the higher liver blood
ﬂow, resulting in lower propofol concentrations in blood [24]. In the present study
we observed that the increased SBP led to decreased clearance. However, it is
difﬁcult to draw any conclusion about the possible mechanism, since there is no
Table 3 Summary of the ﬁnal
population PD parameters, inter-
subject and residual error
variance estimates of BIS scores
Parameter, unit Basic PK model
Estimate (% CV)
Fixed effect
hEC50, mg/l 1.98 (20%)
hEMAX 100 (Fixed)
Inter-individual variability
xEC50
2 [%] 45.1 (37%)
Residual variability
rprop,Cp
2 [%] 19.1 (28%)
Performance measures
MOF 2647.1
Table 4 The biological rhythms in physiological parameters with statistically signiﬁcant circadian
rhythms monitored in 11 ICU patients sedated with prolonged infusion of propofol
Physiological
parameter
(Symbol)
Parameter, unit Basic model Basic model with rhythm
Heart rate (HR) hHR (beats/min) 90.5 (4.7) 90:5ð4:7Þ 1 þ 0:048ð36Þ cos 2p
24ðt   14ð3:6ÞþTÞ
 
xHR
2 (%) 14.4 (34) 14.7 (34)
rprop,HR
2 (%) 12.4 (44) 11.9 (42)
MOF 2513.893 2482.476 (DMOF =- 31.417)
Body temp.
(TEMP)
hTEMP (C) 37.0 (0.3) 37ð0:3Þ 1 þ 0:00326ð52Þ cos 2p
24ðt   21:4ð9:5ÞþTÞ
 
xTEMP
2 (%) 0.816 (38.6) 0.823 (38)
rprop,TEMP
2 (%) 0.0996 (22) 0.966 (19)
MOF -395.163 -418.75 (DMOF = –23.587)
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patients. In the literature, in contradiction to our ﬁndings, both temperature and
triglyceride concentration was found to inﬂuence the metabolic clearance [21].
The utility of BIS monitoring during prolonged sedation in critically ill patients is
still discussed and the literature data is mostly based on the correlation between
different sedation scores [10, 12, 13]. However, it is routinely used to monitor
degree of anesthesia or sedation. Our results suggest the there is a direct link
Fig. 3 Plot of observed (open circle), population predicted (dashed line) and individual predicted (solid
line) hear rates versus time for the ﬁnal model (Eq. 7) with circadian rhythms. The shaded area represents
the dark period (8 p.m.–8 a.m). Time denotes time that has passed since the start of infusion
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which is in agreement with the EC50 of 2.59 mg/l for the basic model proposed by
Peeters et al. [22]. We did not ﬁnd any statistically signiﬁcant covariates. In the
literature the Sequential Organ Failure Assessments (SOFA) scores was suggested
as a covariate that inﬂuences the EC50 [22]. Unfortunately, we did not collect SOFA
scores to conﬁrm these ﬁndings.
Fig. 4 Plot of observed (open circle), population predicted (dashed line) and individual predicted (solid
line) body temperatures versus time for the ﬁnal model (Eq. 7) with circadian rhythms. The shaded area
represents the dark period (8 p.m.–8 a.m). Time denotes time that has passed since the start of infusion
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All previous animal studies have shown that the maximum hypnotic effect of
general anesthetics was generally obtained during the rest phase, which corresponds
in humans to the night time. The longest duration of propofol anesthesia in rats
occurred during the natural sleep period [16]. Circadian rhythms were observed in
rat hepatic enzyme activity with high values in the activity phase and low values in
the rest phase [29]. Since propofol is mainly metabolized by hepatic microsomal
enzymes, rhythms in propofol concentrations are possible. However, our data
suggest lack of daily ﬂuctuations in the steady-state concentrations and metabolic
clearance of propofol in intensive care unit patients.
Rhythmicity in propofol sedative effects might also be expected, since natural
sleep and anesthesia appear to share a common mechanism [17]. Nelson et al. [17]
noted that propofol sedation is not due to generalized inhibition throughout the
CNS, but it rather involves actions on speciﬁc neuronal pathways, particularly those
in the hypothalamus that underlie NREM sleep. Dispersyn et al. observed
desynchronization of daily rest-activity rhythm in the days following light propofol
anesthesia [30]. Also, the daily variation in GABA-A activity was described in the
cerebral cortex of a hamster [31]. Our results did not conﬁrm a circadian ﬂuctuation
in propofol sedation. The data obtained in animal studies cannot be extrapolated to
ICU patients sedated with prolonged propofol infusion.
Albrecht et al. [32] studied propofol sedative therapy with median frequency
monitoring in trauma and non-trauma patients. They noted that sedation in non-
trauma patients revealed some circadian patterns. In contrast the authors did not
observe any ﬂuctuations in the trauma patients group, where most of them had head
injuries. Similarly, Mc Leod et al. [33] observed that the rhythmicity of sedation
cannot be seen in some severely ill patients. In our study patients were clinically
stable during the study period and those with head injuries were excluded. In the
study by Albrecht et al. propofol plasma concentrations to achieve the same level of
sedation were highest between 8 a.m. and 4 p.m. and lowest between 11 p.m. and 4
a.m. This is in contradiction to our ﬁndings which showed no signiﬁcant circadian
rhythm with respect to BIS score during the constant infusion of propofol.
In our study we noted disturbances in the rhythmicity of the monitored
physiological parameters. We recorded blood pressure, heart rate, body temperature
and blood oxygen saturation every hour during the second and the third day of the
propofol infusion. It is important to examine the circadian blood pressure variations
because the natural rhythm alterations are known to inﬂuence life expectancy
[33–36]. Both heart rate and blood pressure exhibit a strong circadian pattern with the
values typically peaking in the morning. Normally, the blood pressure rises rapidly in
theearlymorninghoursduetoincreasedplasmareninactivityandincreasedsecretion
ofcatecholamines.Inthelatemorning(atabout9–10a.m.)thebloodpressurereaches
its peak [34]. After that blood pressure declines and is the lowest between midnight
and 3 a.m. In our study no BP rhytmicity was detected; suggesting severe disturbance
from the natural pattern. For healthy subjects the heart rate reaches its peak around
11–12a.m.andanightlyfallbyabout10%isobserved[35,37].Pauletal.[35]noteda
minor nocturnal fall in the ICU patients heart rate, the day–night difference equaled
3.4 beats/min (3.2% of the mean heart rate value). This is comparable to our ﬁndings.
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p.m. with an amplitude of 0.38C around the mean of 36.6C. The minimum of
body temperature is observed in the early morning, around 4 a.m. [38, 39]. The
administration of sedatives is thought to suppress temperature rhythms directly by
an effect on oscillators, or indirectly through an effect on consciousness [33]. Paul
et al. [35] did not note any normal circadian pattern in body temperatures of the
intensive care patients, although the authors observed a small decrease at night. The
mean day value of the body temperature was 37.9 ± 1.3C, whereas the mean night
value was 37.6 ± 1.3C. In our study, similarly to normal human variations, the
patients’ body temperature tended to be lower in the morning and then increased
during the day. We obtained some signiﬁcant day-night difference in the body
temperature proﬁle; however, a low amplitude of the mean body temperature
rhythm was noted (0.12C).
The limitation of our study was the lack of biochemical monitoring. The
variations in all the monitored physiological parameters may be strongly connected
with the circadian proﬁles of circulating melatonin, cortisol, norepinephrine,
aldosterone, and other hormones. Some alterations in the concentration of these
substances have been observed due to various disease states and sedative agents
given [35, 36, 40].
Conclusions
The light–dark cycle did not inﬂuence propofol pharmacokinetics and pharmaco-
dynamics in intensive care unit patients. According to other monitored parameters
rhythm disturbances were observed when compared to the well known rhythmic
24 h patterns. We observed circadian rhythms for heart rate and body temperature,
however with very small amplitude. The lack of night–day difference was noted for
both systolic and diastolic blood pressure and blood oxygen saturation. Our results
support the hypothesis that endogenous rhythms in critically ill and sedated patients
are severely disturbed and desynchronized.
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